Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science